Clinical Trials Browser

Breast × Clear all

NCT02874430 2026-04-22

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Phase 2 Terminated

29 enrolled 11 charts

Breast Neoplasms

NCT04521686 2026-04-22

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Phase 1 Active not recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Glioblastoma, Glioma, Melanoma, Prostatic Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Cholangiocarcinoma

NCT04595565 2026-04-22

SASCIA

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT04692831 2026-04-22

Testing a New Imaging Agent to Identify Cancer

Phase 1 Active not recruiting

HER-2 Positive Malignant Carcinoma of Breast

NCT04837820 2026-04-22

The Effect of Acupuncture on Cancer-Related Cognitive Difficulties

Phase 2 Active not recruiting

Breast Neoplasms

NCT05130801 2026-04-22

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

Phase 1/2 Recruiting

Breast Neoplasms

NCT05455619 2026-04-22

Amelia-1

Phase 1/2 Recruiting

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance

NCT05596409 2026-04-22

ELCIN

Phase 2 Active not recruiting

Breast Neoplasms

NCT05683418 2026-04-22

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

Phase 1 Recruiting

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT06027268 2026-04-22

ToPCourT

Phase 2 Active not recruiting

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT06215469 2026-04-22

Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

Phase NA Active not recruiting

Alopecia, Breast Neoplasms

NCT06257264 2026-04-22

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Phase 1 Recruiting

BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06347068 2026-04-22

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

Phase 1 Recruiting

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

NCT06512350 2026-04-22

Identifying Patterns in the Breath of Individuals With Breast Cancer

Breast Neoplasms

NCT06949410 2026-04-22

HER2 Vaccine for Locally Advanced Breast Cancer

Phase 1 Recruiting

Breast Neoplasms

NCT07069595 2026-04-22

PREDICT-RD

Phase 2 Recruiting

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07123649 2026-04-22

I-MAMMO

Phase 2 Recruiting

Breast Neoplasms

NCT07198581 2026-04-22

ALLIANCE

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07222267 2026-04-22

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Phase 1 Recruiting

Breast Neoplasms

NCT07238088 2026-04-22

MAMO

Phase NA Recruiting

Breast Neoplasms

NCT07328516 2026-04-22

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Enrolling by invitation

64,277 enrolled

BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Breast Neoplasms, Leukemia, Melanoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT07331077 2026-04-22

A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial

Phase NA Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT07374796 2026-04-22

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT07536867 2026-04-22

SPSIP-RIB

Phase NA Not yet recruiting

Breast Neoplasms, Pain, Postoperative

NCT07543536 2026-04-22

MEGA-TACT-BC3

Phase 3 Not yet recruiting

Breast Neoplasms

NCT07544056 2026-04-22

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

Phase 2/3 Not yet recruiting

Triple Negative Breast Neoplasms

NCT07544134 2026-04-22

APRESERVE-1

Phase NA Not yet recruiting

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT07545044 2026-04-22

A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07545122 2026-04-22

CT-202

Phase 1 Not yet recruiting

BreastGastrointestinal

Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07545434 2026-04-22

Ν/Α

Breast Neoplasms

NCT07546331 2026-04-22

Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction

Breast Neoplasms

NCT00034216 2026-04-21

Collection of Blood From Patients With Cancer

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms

NCT01027416 2026-04-21

Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

Phase NA Completed

59 enrolled 10 charts

Breast Neoplasms

NCT01521676 2026-04-21

BC-BIO

Phase NA Terminated

Breast Neoplasms

NCT01589861 2026-04-21

PIKHER2

Phase 1/2 Terminated

Breast Neoplasms

NCT01980277 2026-04-21

TAKTIC

Phase 1/2 Terminated

Breast Neoplasms

NCT02204098 2026-04-21

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Phase 1 Active not recruiting

Breast Neoplasms

NCT02398773 2026-04-21

FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

Phase 2 Active not recruiting

HER2/Neu Negative

NCT02525211 2026-04-21

Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment

Phase 3 Terminated

Breast Neoplasms

NCT02744053 2026-04-21

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

Triple Negative Breast Neoplasms

NCT02957968 2026-04-21

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

Phase 2 Active not recruiting

46 enrolled 21 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03483012 2026-04-21

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

Phase 2 Completed

6 enrolled 19 charts

Breast Neoplasms

NCT03927027 2026-04-21

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Phase 3 Active not recruiting

Breast Neoplasms

NCT03961685 2026-04-21

CALM

Active not recruiting

Breast Neoplasms

NCT04001829 2026-04-21

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

Phase 2 Active not recruiting

249 enrolled 14 charts

Anatomic Stage I Breast Cancer AJCC v8

NCT04003038 2026-04-21

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Phase NA Recruiting

Breast Neoplasms, Obesity

NCT04732598 2026-04-21

AMBITION

Phase 3 Completed

Breast Neoplasms

NCT04964934 2026-04-21

SERENA-6

Phase 3 Active not recruiting

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT05049746 2026-04-21

Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy

Phase NA Active not recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT05153187 2026-04-21

Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan

1,170 enrolled 16 charts

Breast Neoplasms